Row
L
LXRXAI Stock Diagnostic Report
Lexicon Pharmaceuticals GAAP EPS of -$0.07 misses by $0.02, revenue of $28.9M beats by $24.9M
Lexicon Pharmaceuticals' Q2 2026 EPS fell short of expectations, but revenue significantly exceeded forecasts, resulting in mixed performance.
View Source Article ↗AI CATALYST SCORE50 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time